Thierry Lequerré

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

Thierry Lequerré, Pierre Quartier, David Rosellini et al. · Annals of the Rheumatic Diseases · 2007 · 404 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +11

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

Jacques‐Eric Gottenberg, G. Cinquetti, C. Larroche et al. · Annals of the Rheumatic Diseases · 2012 · 222 citations

Life Sciences, Immunology, Internal Medicine +13

Mevalonate Kinase Deficiency: A Survey of 50 Patients

Brigitte Bader‐Meunier, Benoît Florkin, Jean Sibilia et al. · PEDIATRICS · 2011 · 218 citations

Medicine, Immunology, Molecular Medicine +12

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

Thierry Lequerré, Anne-Christine Gauthier-Jauneau, Carine Bansard et al. · Arthritis Research & Therapy · 2006 · 166 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Anakinra in Adult‐Onset Still's Disease: Long‐Term Treatment in Patients Resistant to Conventional Therapy

Cecilia Giampietro, Meriem Ridene, Thierry Lequerré et al. · Arthritis Care & Research · 2012 · 115 citations

Medicine, Pharmacology, Pharmacotherapy +14